Air T (AIRT)
(Delayed Data from NSDQ)
$16.88 USD
-0.47 (-2.71%)
Updated Oct 17, 2024 04:00 PM ET
After-Market: $16.80 -0.08 (-0.47%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$16.88 USD
-0.47 (-2.71%)
Updated Oct 17, 2024 04:00 PM ET
After-Market: $16.80 -0.08 (-0.47%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
The Zacks Analyst Blog Highlights Toyota Motor, AstraZeneca, Chubb, Air T and Preformed Line Products
by Zacks Equity Research
Toyota Motor, AstraZeneca, Chubb, Air T and Preformed Line Products are part of the Zacks top Analyst Blog.
Top Stock Reports for Toyota, AstraZeneca & Chubb
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Toyota Motor Corp. (TM), AstraZeneca PLC (AZN) and Chubb Ltd. (CB), as well as two micro-cap stocks Air T, Inc. (AIRT) and Preformed Line Products Co. (PLPC).
Air T (AIRT) Q1 Earnings Increase Y/Y, Revenues Decline
by Zacks Equity Research
Despite strength in Air T's (AIRT) Overnight Air Cargo and Corporate and Other segments, overall fiscal first-quarter revenues decline year over year.
The Zacks Analyst Blog Highlights Novo Nordisk, AbbVie, AstraZeneca, Air T and United-Guardian
by Zacks Equity Research
Novo Nordisk, AbbVie, AstraZeneca, Air T and United-Guardian are included in this Analyst Blog.
Air T's (AIRT) Fiscal 2024 Earnings, Revenues Improve Y/Y
by Zacks Equity Research
Air T's (AIRT) overall topline benefits from revenue growth in the majority of its segments.
Zacks Initiates Coverage of Air T With Neutral Recommendation
by Debanjana Dey
Find out why Zacks rates Air T as "Neutral," being the first on Wall Street to initiate coverage on the stock. Explore AIRT's strategic acquisitions and financial health amid market challenges.